SEK 0.97
(-1.62%)
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2023 | 995 Thousand SEK | -981.63% |
2022 | -21.38 Million SEK | 14.58% |
2021 | -25.02 Million SEK | 21.83% |
2020 | -32.02 Million SEK | -14.96% |
2019 | -27.85 Million SEK | -39.35% |
2018 | -19.98 Million SEK | -119.41% |
2017 | -9.11 Million SEK | -33.83% |
2016 | -6.8 Million SEK | 0.0% |
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2024 Q1 | -57.16 Million SEK | -3.39% |
2024 Q2 | -65.35 Million SEK | -14.32% |
2023 Q2 | -2.13 Million SEK | -181.69% |
2023 FY | -231.25 Million SEK | -981.63% |
2023 Q1 | 2.61 Million SEK | 158.16% |
2023 Q4 | -55.29 Million SEK | -16115.54% |
2023 Q3 | -341 Thousand SEK | 84.01% |
2022 FY | -21.38 Million SEK | 14.58% |
2022 Q4 | -4.48 Million SEK | -11.56% |
2022 Q3 | -4.02 Million SEK | 33.02% |
2022 Q2 | -6 Million SEK | 13.62% |
2022 Q1 | -6.95 Million SEK | -99.06% |
2021 Q2 | -8.32 Million SEK | 8.75% |
2021 FY | -25.02 Million SEK | 21.83% |
2021 Q3 | -4.09 Million SEK | 50.82% |
2021 Q4 | -3.49 Million SEK | 14.61% |
2021 Q1 | -9.11 Million SEK | -95.67% |
2020 FY | -32.02 Million SEK | -14.96% |
2020 Q4 | -4.66 Million SEK | 27.19% |
2020 Q2 | -11.1 Million SEK | -19.14% |
2020 Q3 | -6.4 Million SEK | 42.37% |
2020 Q1 | -9.32 Million SEK | 25.68% |
2019 Q2 | -5.67 Million SEK | -0.59% |
2019 FY | -27.85 Million SEK | -39.35% |
2019 Q4 | -12.54 Million SEK | -213.63% |
2019 Q3 | -3.99 Million SEK | 29.51% |
2019 Q1 | -5.64 Million SEK | 2.57% |
2018 Q2 | -5.36 Million SEK | -7.18% |
2018 Q3 | -3.83 Million SEK | 28.45% |
2018 Q1 | -5 Million SEK | -57.49% |
2018 Q4 | -5.78 Million SEK | -50.91% |
2018 FY | -19.98 Million SEK | -119.41% |
2017 FY | -9.11 Million SEK | -33.83% |
2017 Q2 | -1.58 Million SEK | -0.93% |
2017 Q3 | -2.79 Million SEK | -76.93% |
2017 Q4 | -3.17 Million SEK | -13.47% |
2017 Q1 | -1.56 Million SEK | 0.0% |
2016 FY | -6.8 Million SEK | 0.0% |
Name | Gross Profit | Gross Profit Difference |
---|---|---|
AddLife AB (publ) | 2.77 Billion SEK | 99.964% |
Biotage AB (publ) | 1.14 Billion SEK | 99.913% |
Bonesupport Holding AB (publ) | 533.12 Million SEK | 99.813% |
Doxa AB (publ) | 9.9 Million SEK | 89.949% |
Elekta AB (publ) | 6.77 Billion SEK | 99.985% |
iZafe Group AB (publ) | 293 Thousand SEK | -239.59% |
Ortivus AB (publ) | 30.84 Million SEK | 96.774% |
Ortivus AB (publ) | 30.84 Million SEK | 96.774% |
S2Medical AB (publ) | 5.03 Million SEK | 80.246% |
Synsam AB (publ) | 617 Million SEK | 99.839% |